Company Filing History:

11 out of 1,858

Takeda Chemical Industries, Inc.

patents

2 out of 1,179

Takeda Pharmaceutical Company Limited

patents

1 out of 1

Takeda Chemical Industires, Ltd.

patent

Years Active: 1990-2006

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7091247 - Biphenyl compound (2006-08-15),

2. 7087597 - Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof (2006-08-08),

3. 6388022 - Linker binding carriers for organic synthesis, their production and use (2002-05-14),

4. 6174877 - Carbapenem compound, their production and use (2001-01-16),

5. 5539113 - Pyrrolopyrimidine derivatives, their production (1996-07-23),

6. 5496946 - Production of pyrrolopyrimidines and intermediates therefor (1996-03-05),

7. 5459260 - Tricyclic or tetracyclic carbapenem compounds, their production and use (1995-10-17),

8. 5393751 - Tricyclic carbapenem compounds (1995-02-28),

9. 5349064 - Production of pyrrolopyrimidines (1994-09-20),

10. 5296600 - Pyrrolopyrimidine derivatives, their production and use (1994-03-22),

11. 5223620 - Pyrido[2,3-d]pyrimidine compounds useful as intermediates (1993-06-29),

12. 5106974 - Pyrrolopyrimidine derivatives (1992-04-21),

13. 4997838 - Pyrrolopyrimidine derivatives, their production and use (1991-03-05),

14. 4946846 - Fused pyrimidines, their production and use (1990-08-07),

Title: The Innovative Mind of Tetsuo Miwa

Introduction

Tetsuo Miwa is a prominent inventor hailing from Kobe, Japan, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 14 patents, Miwa's work focuses primarily on the development of innovative compounds aimed at addressing various health conditions.

Latest Patents

Among his latest patents, Miwa has developed a novel biphenyl compound exhibiting GPR 14 antagonistic activity. This biphenyl compound, represented by a specific chemical formula, includes essential elements such as hydrocarbon groups and benzene rings, showcasing its potential in medical applications. Another noteworthy patent is his work on pyrimidine 5-carboxamide compounds, which demonstrate superior cGMP-specific phosphodiesterase (PDE) inhibitory activity. These compounds show promise in treating cardiovascular diseases, allergic conditions like asthma, and disorders related to male and female genital functions.

Career Highlights

Tetsuo Miwa has enjoyed a distinguished career, marked by significant stints at renowned companies within the pharmaceutical industry. He has been associated with Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited, where he contributed his expertise to groundbreaking research and development efforts.

Collaborations

Throughout his career, Miwa has collaborated with several esteemed colleagues, including Hiroshi Akimoto and Takenori Hitaka. These partnerships have fostered a dynamic environment for innovation and collective problem-solving in advancing pharmaceutical science.

Conclusion

Tetsuo Miwa continues to exemplify ingenuity and dedication in his field, with a strong focus on developing innovative therapeutic solutions. His contributions not only advance scientific knowledge but also hold the potential to improve the quality of life for many individuals facing health challenges.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com